Novel CD8+ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice. (Q53175345)

From Wikidata

Jump to navigation Jump to search

scientific article published on 6 April 2012

Language	Label	Description	Also known as
English	Novel CD8+ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice.	scientific article published on 6 April 2012

Statements

scholarly article

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22484292

Novel CD8+ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice. (English)

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22484292

author name string

Roopa Hebbandi Nanjundappa

1

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22484292

Rong Wang

2

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22484292

Yufeng Xie

3

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22484292

Channakeshava Sokke Umeshappa

4

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22484292

Jim Xiang

5

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22484292

language of work or name

0 references

publication date

6 April 2012

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22484292

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22484292

30

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22484292

24

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22484292

3519-3525

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22484292

Maturation of dendritic cells for enhanced activation of anti-HIV-1 CD8(+) T cell immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Efficient in vitro expansion of human immunodeficiency virus (HIV)-specific T-cell responses by gag mRNA-electroporated dendritic cells from treated and untreated HIV type 1-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Induction of protective immune responses against R5 human immunodeficiency virus type 1 (HIV-1) infection in hu-PBL-SCID mice by intrasplenic immunization with HIV-1-pulsed dendritic cells: possible involvement of a novel factor of human CD4(+) T-ce

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Macaque dendritic cells infected with SIV-recombinant canarypox ex vivo induce SIV-specific immune responses in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Amplification of low-frequency antiviral CD8 T cell responses using autologous dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Therapeutic dendritic-cell vaccine for chronic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Therapeutic Immunization with Dendritic Cells Loaded with Heat‐Inactivated Autologous HIV‐1 in Patients with Chronic HIV‐1 Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Peptide-loaded dendritic-cell vaccination followed by treatment interruption for chronic HIV-1 infection: a phase 1 trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Novel exosome-targeted CD4+ T cell vaccine counteracting CD4+25+ regulatory T cell-mediated immune suppression and stimulating efficient central memory CD8+ CTL responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

A new dynamic model of CD8+ T effector cell responses via CD4+ T helper-antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

CD4+ Th-APC with acquired peptide/MHC class I and II complexes stimulate type 1 helper CD4+ and central memory CD8+ T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

GP120-specific exosome-targeted T cell-based vaccine capable of stimulating DC- and CD4(+) T-independent CTL responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Recognition of variant HIV-1 epitopes from diverse viral subtypes by vaccine-induced CTL

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Vaccination of fiber-modified adenovirus-transfected dendritic cells to express HER-2/neu stimulates efficient HER-2/neu-specific humoral and CTL responses and reduces breast carcinogenesis in transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Membrane-bound HSP70-engineered myeloma cell-derived exosomes stimulate more efficient CD8(+) CTL- and NK-mediated antitumour immunity than exosomes released from heat-shocked tumour cells expressing cytoplasmic HSP70.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

CD8+ cytotoxic T-APC stimulate central memory CD8+ T cell responses via acquired peptide-MHC class I complexes and CD80 costimulation, and IL-2 secretion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Cytotoxic T lymphocytes kill multiple targets simultaneously via spatiotemporal uncoupling of lytic and stimulatory synapses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Structure-function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Conserved HIV-1 epitopes continuously elicit subdominant cytotoxic T-lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Immunology and the elusive AIDS vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Long-term control of simian immunodeficiency virus replication with central memory CD4+ T-cell preservation after nonsterile protection by a cytotoxic T-lymphocyte-based vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

T-cell vaccination reduces simian immunodeficiency virus levels in semen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

T cell responses generated by HIV vaccines in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Problems and emerging approaches in HIV/AIDS vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Evaluation of antitumor immunity efficacy of epitope-based vaccine with B16 cell line coexpressing HLA-A2/H-2kb and CTL multiepitope in HLA transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Multiple roles for CD4+ T cells in anti-tumor immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

T-cell quality in memory and protection: implications for vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection Workshop in dendritic cell-based vaccine clinical trials in HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.075

7 January 2021

Identifiers

10.1016/J.VACCINE.2012.03.075

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22484292

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/22484292

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53175345&oldid=1369022777"